China Resources Medical Holdings Company Limited (1PH) — Net Asset Quality Index
China Resources Medical Holdings Company Limited (1PH) has a Net Asset Quality Index of 57.2% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €13.59 Billion minus total liabilities of €5.82 Billion yields net assets of €7.77 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check China Resources Medical Holdings Company (1PH) asset resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
China Resources Medical Holdings Company Limited Net Asset Quality Index Over Time (2016–2024)
This chart shows how China Resources Medical Holdings Company Limited's Net Asset Quality Index has evolved across 9 annual periods from 2016 to 2024. As of June 2025, the index stands at 57.2%, representing net assets of €7.77 Billion against total assets of €13.59 Billion EUR. See working capital position of China Resources Medical Holdings Company to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for China Resources Medical Holdings Company Limited (2016–2024)
The table below presents the year-by-year Net Asset Quality Index for China Resources Medical Holdings Company Limited from 2016 to 2024, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is China Resources Medical Holdings Company worth.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 56.3% | €7.50 Billion | €13.32 Billion | €5.82 Billion | ▲ +4.9 pp |
| 2023 | 51.4% | €7.01 Billion | €13.65 Billion | €6.64 Billion | ▼ -11.7 pp |
| 2022 | 63.0% | €7.00 Billion | €11.10 Billion | €4.11 Billion | ▼ -2.4 pp |
| 2021 | 65.4% | €6.85 Billion | €10.47 Billion | €3.62 Billion | ▼ -5.3 pp |
| 2020 | 70.7% | €6.34 Billion | €8.96 Billion | €2.62 Billion | ▼ -7.2 pp |
| 2019 | 78.0% | €6.14 Billion | €7.87 Billion | €1.73 Billion | ▼ 0.0 pp |
| 2018 | 78.0% | €5.71 Billion | €7.32 Billion | €1.61 Billion | ▼ -3.0 pp |
| 2017 | 81.0% | €5.60 Billion | €6.91 Billion | €1.31 Billion | ▼ -2.1 pp |
| 2016 | 83.1% | €5.36 Billion | €6.45 Billion | €1.09 Billion | — |